Isotretinoin and the risk of erythema multiforme: Final SPC and PL wording
18.11.2010
Isotretinoin and the risk of erythema multiforme: Final SPC and PL wording
Isotretinoin and the risk of erythema multiforme: Final SPC and PL wording
BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte
Navigation und Service
